Structure via PubChem · Public domain (PubChem)
bromperidol
Sign in to saveBromperidol, sold under the brand names Bromidol and Impromen among others, is a typical antipsychotic of the butyrophenone group which is used in the treatment of schizophrenia. It was discovered at Janssen Pharmaceutica in 1966. An ester prodrug, bromperidol decanoate, is a long-acting form of bromperidol used as a depot injectable.
Chemical data
- Formula
- C21H23BrFNO2
- Molecular weight
- 420.3 g/mol
- IUPAC name
- 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- Indications
- psychosis, anxiety, Dementia, depressive disorder
via ChEMBL · EBI
Research
164 papers- Depot bromperidol decanoate for schizophrenia.The Cochrane database of systematic reviews · 2004
- Bromperidol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in psychoses.Drugs · 1988
- Bromperidol decanoate (depot) for schizophrenia.The Cochrane database of systematic reviews · 2012
- Bromperidol decanoate (depot) for schizophrenia.The Cochrane database of systematic reviews · 2011
- Depot bromperidol decanoate for schizophrenia.The Cochrane database of systematic reviews · 2000
via PubMed
~1 min read
Encyclopedic overview
2 sectionsContents
- References
- Further reading
Bromperidol, sold under the brand names Bromidol and Impromen among others, is a typical antipsychotic of the butyrophenone group which is used in the treatment of schizophrenia. It was discovered at Janssen Pharmaceutica in 1966. An ester prodrug, bromperidol decanoate, is a long-acting form of bromperidol used as a depot injectable.
==References==
Excerpted from Wikipedia’s “bromperidol” article, available under the CC BY-SA 4.0 licence.
Available in 10 languages
via Wikidata sitelinks · CC0